It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
Highlights
•
Combined treatment with the α2A-adrenoceptor agonist, guanfacine, and the anti-oxidant, N-acetylcysteine (NAC) reduced the cognitive deficits (“brain fog”) associated with long-COVID19 in eight out of twelve patients.
•
Two patients stopped treatment due to hypotension and/or dizziness, common side effects of guanfacine, and two patients were lost to follow-up.
•
The remaining eight patients reported improved working memory, concentration and executive function, including the resumption of normal workloads.
•
One patient temporarily stopped guanfacine due to a hypotensive episode and reported a return of cognitive deficits that abated with resumed guanfacine treatment.
•
Although placebo-controlled trials will be needed to demonstrate efficacy, the established safety of guanfacine and NAC suggests they may be immediately useful in treating the cognitive deficits of long-COVID19.
originally posted by: tamusan
N-acetylcysteine (NAC), an anti-inflammatory and antioxidant supplement, is the name of the second medication.
originally posted by: butcherguy
The FDA was considering a ban on NAC as an OTC supplement. For now, AFAIK, they are in a hold pattern as to a final decision.
originally posted by: DontTreadOnMe
a reply to: MykeNukem
Long covid exists among the unvaccinated.
People still suffering since early 2020 in some cases....and some being told It's all in their heads.
People never jabbed who get L.C. symptoms after the acute phase of the virus resolves.